Details
Category: Volume 07 Issue 04 April 2019
Hits: 1496

Title: Recurrent Epitheloid Cell Sarcoma of Scapular region: A Case Report and Review of Literature

Authors: Raza MW, Verma S, Prasad SN, Misra MP

 DOI: https://dx.doi.org/10.18535/jmscr/v7i4.29

Abstract

Epithelioid sarcoma is a rare variety of malignant soft tissue sarcoma of uncertain differentiation that affects young adults mostly involves upper arm especially arm and wrist. It has a high rate of recurrence and metastasis. A 55-year-old male presented in December 2011 with a swelling over right scapular region (near angle of scapula). The patient gave a history of swelling from 6 months. Local excision was done 2 times from 2014 to 2016. Each time the recurrence was just distal to previous one. For the third recurrence just adjacent to it wide local excision was done. Immunohistochemistry (IHC) showed expression of Vimentin, Pan-CK: Focal positive, EMA: Focal positive, LCA: negative, CD-99: Negative,. IHC confirmed the diagnosis of epithelioid sarcoma of axillary region. Patient received adjuvant chemotherapy followed by local radiotherapy. Patient remained asymptomatic for 2 years when follow up PET-CT was suggestive of lung metastasis. Thus, doxorubicin based chemotherapy has been planned.

Keywords: Doxorubicin, epithelioid sarcoma, immunohistochemistry, wide local excision, Scapula.

References

  1. Enzinger FM. Epitheloid sarcoma. A sarcoma simulating a granuloma or a carcinoma. Cancer 1970; 26:1029-41.  
  2. Alderman AK, Kim HM, Kotsis SV, Chung KC. Upper-extremity sarcomas in the United States: Analysis of the surveillance, epidemiology, and end results database, 1973-1998. J Hand Surg Am 2003;28:511-8.  
  3. Jawad MU, Extein J, Min ES, Scully SP. Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database. Clin Orthop Relat Res 2009;467:2939-48. 
  4. McPhee M, McGrath BE, Zhang P, Driscoll D, Gibbs J, Peimer C. Soft tissue sarcoma of the hand. J Hand Surg Am 1999;24:1001-7. 
  5. Chase DR, Enzinger FM. Epithelioid sarcoma. Diagnosis, prognostic indicators, and treatment. Am J Surg Pathol 1985;9:241-63.  
  6. Halling AC, Wollan PC, Pritchard DJ, Vlasak R, Nascimento AG. Epithelioid sarcoma: a clinicopathologic review of 55 cases. Mayo Clin Proc. 1996;71:636–642.
  7. Bos GD, Pritchard DJ, Reiman HM, Dobyns JH, Ilstrup DM, Landon GC. Epithelioid sarcoma. An analysis of fifty-one cases. J Bone Joint Surg Am 1988;70:862-70
  8. Herr MJ, Harmsen WS, Amadio PC, Scully SP. Epithelioid sarcoma of the hand. Clin Orthop Relat Res 2005;193-200.  
  9. Charest M, Hickeson M, Lisbona R, Novales-Diaz JA, Derbekyan V, Turcotte RE. FDG PET/CT imaging in primary osseous and soft tissue sarcomas: A retrospective review of 212 cases. Eur J Nucl Med Mol Imaging 2009;36:1944-51.  
  10. Hornick et al: Loss of INI1 expression is characteristic of both conventional and proximal type epitheliod sarcoma. Am J of Surg Pathol. 33(4):542-550, 2009
  11. Rydholm A, Gustafson P, Rooser B, et al. Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma. J Clin Oncol 1991;9:1757-1765
  12. Cahlon O, Brennan MF, Jia X, et al. A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limbsparing surgery without adjuvant radiation. Ann Surg 2012;255: 343-347
  13. Chbani L, Guillou L, Terrier P, Decouvelaere AV, Grégoire F, Terrier-Lacombe MJ, et al.Epithelioid sarcoma: A clinicopathologic and immunohist-ochemical analysis of 106 cases from the French sarcoma group. Am J Clin Pathol2009;131:222-7.  
  14. Miettinen M, Fanburg-Smith JC, Virolainen M, Shmookler BM, Fetsch JF. Epithelioid sarcoma: An immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol 1999;30:934-42.  
  15. Chase DR, Enzinger FM. Epithelioid sarcoma. Diagnosis, prognostic indicators, and treatment. Am J Surg Path 1985;9:241-63
  16. de Visscher SAHJ, Ginkel RJ, Wobbes T, Veth RPH, Heuvel SE, Suurmeijer AJH, et al. Epithelioid sarcoma: still an only surgically curable disease. Cancer 2006;107:606-12
  17. Singh RP, Grimer RJ, Bhujel N, Carter SR, Tillman RM, Abudu A. Adult head and neck soft tissue sarcomas: treatment and outcome. Sarcoma 2008;2008:654987
  18. Baldini EH, Goldberg J, Jenner C, et al. Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol 1999;17:3252-3259.
  19. Pisters PW, Pollock RE, Lewis VO, et al. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg 2007;246:675e681. discussion 681-682
  20. Blazer DG 3 rd, Sabel MS, Sondak VK. Is there a role for sentinel lymph node biopsy in the management of sarcoma? Surg Oncol 2003;12:201-6.  
  21. Callister MD, Ballo MT, Pisters PW, Patel SR, Feig BW, Pollock RE, et al.  Epithelioid sarcoma: Results of conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2001;51:384-91
  22. Wolf PS. Epithelioid Sarcoma: The University of Washington Experience. CTOS Annual Meeting Presentation; 2005.     
  23. Shimm DS and Suit HD, Radiation Therapy of Epithelioid Sarcoma, Cancer 1983; 52:1022-1025
  24. Laney TF, Kepka L, Goldberg SI, Hornicken FJ, Gebhardt, Yoon SS, et al. Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys 2007;67:1460-7
  25. Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, et al. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol. 2007;25(21):3144-50.
  26. Judson I, Verweij J, Gelderblom H, Hartmann JT, Schöffski P, Blay JY, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014;15(4):415-23.
  27. Seddon B, Strauss SJ, Whelan J, Leahy M, Woll PJ, Cowie F, et al. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. Lancet Oncol. 2017;18(10):1397-410
  28. Kim C, Kim EK, Jung H, Chon HJ, Han JW, Kyoo-Ho Shin, et al. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma. BMC Cancer. 2016;16:434.

Corresponding Author

Raza MW